Difficulty: Medium
Average Score: 85%
Simulated
The MMR vaccine (measles, mumps, and rubella) is given subcutaneously at a dose of 0.5 mL if the patient is not immune to rubella. How should the risk of Venous Thromboembolism (VTE) and Postpartum Hemorrhage (PPH) be evaluated?
Correct answer
B
Rationale
MMR vaccination does not directly increase VTE or PPH risk. Evaluating based on overall health and pregnancy factors, with prophylaxis for moderate to high risk, is appropriate per policy.